Prescription drug · ANDA
Milrinone Lactate in Dextrose NDC 0143-9718
Milrinone lactate 200 ug/mL · Injection, Solution · Intravenous · Hikma Pharmaceuticals USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0143-9718-10 | 0014397181000143971810 | 10 CONTAINER in 1 PACKAGE (0143-9718-10) / 200 mL in 1 CONTAINER (0143-9718-01)Marketed from Jan 21, 2010 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Milrinone Lactate in Dextrose
- Generic name (nonproprietary)
- milrinone lactate in dextrose
- Active ingredients
- Milrinone lactate — 200 ug/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Hikma Pharmaceuticals USA Inc.NDC labeler code 0143
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090038
- Marketing start
- Listing expires
- Other FDA classes
- Phosphodiesterase 3 Inhibitors (Mechanism)
- Identifiers
- Product ID 0143-9718_e67caf04-0a9c-4638-90a6-c959c9e0b927SPL ID e67caf04-0a9c-4638-90a6-c959c9e0b927SPL set ID 4c2f052b-7ba2-4122-a50b-37ef2a834d61RxCUI 1791840, 1791842UNII 9K8XR81MO8
- Pharmacologic class
- Phosphodiesterase 3 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400143971810followed by a unit qualifier and the quantityPackage 00143-9718-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Milrinone lactate injection is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. Patients receiving milrinone should be observed closely with appropriate electrocardiographic equipment. The facility for immediate treatment of potential cardiac events, which may include life threatening ventricular arrhythmias, must be available. The majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics. There is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours.
Excerpt only. Read the full label for complete information.
About NDC 0143-9718
- What is NDC 0143-9718?
- 0143-9718 is the product NDC for Milrinone Lactate in Dextrose, Milrinone lactate 200 ug/mL injection, solution, listed with the FDA by Hikma Pharmaceuticals USA Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Milrinone Lactate in Dextrose.
- What is the active ingredient?
- Milrinone lactate.
- Who is the labeler?
- Hikma Pharmaceuticals USA Inc., NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Milrinone Lactate in Dextrose?
- 8 other product NDCs are listed under this name. See all Milrinone Lactate in Dextrose NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Milrinone Lactate in Dextrose products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Milrinone Lactate in Dextrose | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-2045 | 00409-2045-10 |
| Milrinone Lactate in Dextrose | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Hospira, Inc. | 0409-1983 | 00409-1983-10 |
| Milrinone Lactate in Dextrosemilrinone lactate | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Sagent Pharmaceuticals | 25021-313 | 25021-0313-8225021-0313-87 |
| Milrinone Lactate in Dextrosemilrinone lactate | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Gland Pharma Limited | 68083-410 | 68083-0410-10 |
| Milrinone Lactate in Dextrosemilrinone lactate | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Gland Pharma Limited | 68083-411 | 68083-0411-10 |
| Milrinone Lactate in Dextrose | Milrinone lactate 200 ug/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9719 | 00143-9719-10 |
| Milrinone Lactate in Dextrosemilrinone lactate | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-6010 | 00338-6010-48 |
| Milrinone Lactate in Dextrosemilrinone lactate | Milrinone lactate .2 mg/mL | Injection, SolutionIntravenous | Baxter Healthcare Corporation | 0338-6011 | 00338-6011-37 |
Other NDCs under ANDA 090038
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Milrinone Lactate in Dextrose | Milrinone lactate 200 ug/mL | Injection, SolutionIntravenous | Hikma Pharmaceuticals USA Inc. | 0143-9719 |